The research company Peptonic Medical’s board has decided to carry out a rights issue as part of the company’s reconstruction. This is stated in a press release. The company will, upon full subscription, receive SEK 14.9 million before issue costs, which are estimated to amount to a maximum of SEK 1.7 million. The terms mean that one share gives one unit right. One unit right entitles the holder to subscribe for one unit for SEK 0.16. One unit consists of 100 new shares and 100 free-of-charge warrants TO 6. The terms thus correspond to 100:1 at a subscription price of SEK 0.0016 per share. The last day for trading in the share including unit right is 7 January, and the share trades excluding unit right on 8 January. The subscription period runs from 14 to 28 January, and trading in unit rights takes place from 14 to 23 January.